Literature DB >> 2617203

A new peptide for human parvovirus B19 antibody detection.

E Fridell1, J Trojnar, B Wahren.   

Abstract

A serological assay for human parvovirus B19 was developed. Linear overlapping synthetic peptides were synthesised according to parts of open reading frames 1 and 2. A region at the N-terminus of viral protein VP2 detected serological reactivity in indirect enzyme-linked immunosorbent assays for IgG and IgM with known seropositive human sera. A cyclized peptide taken from this region, amino acids 284-307, gave the best selective reactivity with seropositive and seronegative sera. The peptide assay appears suitable for further studies of B19 infections and their complications.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2617203     DOI: 10.3109/00365548909021686

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  12 in total

1.  New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.

Authors:  T F Schwarz; S Modrow; B Hottenträger; B Höflacher; G Jäger; W Scharti; R Sumazakl; H Wolf; J Middeldorp; M Roggendorf
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Evaluation of commercial enzyme linked immunosorbent assay for detection of B19 parvovirus IgM and IgG.

Authors:  G Patou; U Ayliffe
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

3.  Evaluation of four commercial enzyme immunoassays for detection of immunoglobulin M antibodies to human parvovirus B19.

Authors:  T Sloots; P L Devine
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-09       Impact factor: 3.267

4.  Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction.

Authors:  F McOmish; P L Yap; A Jordan; H Hart; B J Cohen; P Simmonds
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection.

Authors:  L Kaikkonen; H Lankinen; I Harjunpää; K Hokynar; M Söderlund-Venermo; C Oker-Blom; L Hedman; K Hedman
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

6.  Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.

Authors:  S Kajigaya; H Fujii; A Field; S Anderson; S Rosenfeld; L J Anderson; T Shimada; N S Young
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

7.  Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19.

Authors:  A L Bruu; S A Nordbø
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

8.  Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.

Authors:  A Gigler; S Dorsch; A Hemauer; C Williams; S Kim; N S Young; S Zolla-Pazner; H Wolf; M K Gorny; S Modrow
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Evaluation of a synthetic-peptide enzyme-linked immunosorbent assay for immunoglobulin M to human parvovirus B19.

Authors:  E Fridell; B J Cohen; B Wahren
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

10.  Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay.

Authors:  M Söderlund; K E Brown; O Meurman; K Hedman
Journal:  J Clin Microbiol       Date:  1992-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.